Paper15528343
Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
Jinushi M and 8 others. J Immunol, 2004. Cited by 165 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. Papers, record 15528343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15528343
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
- PubMed
Topics29
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Dendritic Cells | Major topic |
| Down-Regulation | Major topic |
| Hepatitis C, Chronic | Major topic |
| Killer Cells, Natural | Major topic |
| Lectins, C-Type | Major topic |
| Receptors, Immunologic | Major topic |
| Cell Differentiation | |
| Cell Line, Tumor | |
| Cell-Free System | |
| Cells, Cultured | |
| Coculture Techniques | |
| HLA Antigens | |
| Histocompatibility Antigens Class I | |
| Humans | |
| Immunophenotyping | |
| Interleukin-10 | |
| K562 Cells | |
| Lymphocyte Activation | |
| Lymphocyte Count | |
| NK Cell Lectin-Like Receptor Subfamily C | |
| NK Cell Lectin-Like Receptor Subfamily D | |
| Receptors, Natural Killer Cell | |
| Signal Transduction | |
| Suppressor Factors, Immunologic | |
| Transforming Growth Factor beta | |
| Up-Regulation | |
| HLA-E Antigens |
Source PubMed
Cited by106
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,666,682 | Hepatitis C virus-associated B-cell non-Hodgkin lymphomas: immune evasion, multistep lymphomagenesis, and candidate biomarkers for risk stratification and disease monitoring. | Front Immunol | 2026 | https://conductscience.org/library/papers/42666682 | PubMed |
| 41,583,436 | From innate-like to innate: the next wave of off-the-shelf CAR immunotherapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583436 | PubMed |
| 40,453,084 | Recent advances in regulatory immune cells: exploring the world beyond Tregs. | Front Immunol | 2025 | https://conductscience.org/library/papers/40453084 | PubMed |
| 39,199,374 | The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199374 | PubMed |
| 38,767,592 | NK-cell receptor modulation in viral infections. | Clin Exp Immunol | 2024 | https://conductscience.org/library/papers/38767592 | PubMed |
| 37,396,514 | Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. | Genes Dis | 2023 | https://conductscience.org/library/papers/37396514 | PubMed |
| 37,371,767 | Non-Classical HLA Class 1b and Hepatocellular Carcinoma. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371767 | PubMed |
| 37,119,279 | Protective and pathogenic functions of innate lymphoid cells in transplantation. | Clin Exp Immunol | 2023 | https://conductscience.org/library/papers/37119279 | PubMed |
| 36,936,055 | Natural killer cells in COVID-19: from infection, to vaccination and therapy. | Future Virol | 2023 | https://conductscience.org/library/papers/36936055 | PubMed |
| 36,311,746 | The liver-resident immune cell repertoire - A boon or a bane during machine perfusion? | Front Immunol | 2022 | https://conductscience.org/library/papers/36311746 | PubMed |
| 35,806,995 | NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial. | J Clin Med | 2022 | https://conductscience.org/library/papers/35806995 | PubMed |
| 35,359,972 | Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/35359972 | PubMed |
| 35,267,563 | Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267563 | PubMed |
| 35,053,151 | Role of IL-10-Producing Natural Killer Cells in the Regulatory Mechanisms of Inflammation during Systemic Infection. | Biomolecules | 2021 | https://conductscience.org/library/papers/35053151 | PubMed |
| 34,452,571 | The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/34452571 | PubMed |
| 34,230,995 | The role of natural killer cells in liver inflammation. | Semin Immunopathol | 2021 | https://conductscience.org/library/papers/34230995 | PubMed |
| 34,178,661 | CAR-NK Cell: A New Paradigm in Tumor Immunotherapy. | Front Oncol | 2021 | https://conductscience.org/library/papers/34178661 | PubMed |
| 34,062,821 | Natural Killer-Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34062821 | PubMed |
| 34,054,844 | Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment. | Front Immunol | 2021 | https://conductscience.org/library/papers/34054844 | PubMed |
| 33,859,642 | IL-10-Producing ILCs: Molecular Mechanisms and Disease Relevance. | Front Immunol | 2021 | https://conductscience.org/library/papers/33859642 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| HLA-E | 3,133 | PubTator's text mining | https://conductscience.org/library/genes/3133 | NCBI Gene |
| IL10 | 3,586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| KIR3DL1 | 3,811 | PubTator's text mining | https://conductscience.org/library/genes/3811 | NCBI Gene |
| KLRC1 | 3,821 | PubTator's text mining | https://conductscience.org/library/genes/3821 | NCBI Gene |
| KLRD1 | 3,824 | PubTator's text mining | https://conductscience.org/library/genes/3824 | NCBI Gene |
| TGFB1 | 7,040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15528343
GET https://conductscience.org/api/papers/v1/15528343/cited_by?page=2